Unjoni Ewropea -
Iżlandiż -
EMA (European Medicines Agency)
jinarc
otsuka pharmaceutical netherlands b.v. - tolvaptan - polycystic nýru, autosomal dominant - Þvagræsilyf, - jinarc er ætlað að hægja á framvindu blaðra þróun og nýrnabilun litnings ríkjandi einn nýrnasjúkdóm (adpkd) í fullorðnir með langvinnan stigi 1 til 3 á upphaf meðferð með sönnunargögn hratt gengur sjúkdómur.
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
quetiapin medical valley forðatafla 300 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 300 mg
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
mitomycin medac duft og leysir fyrir þvagblöðrulausn 40 mg
medac gesellschaft für klinische spezialpräparate gmbh - mitomycinum inn - duft og leysir fyrir þvagblöðrulausn - 40 mg
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
quetiapin medical valley forðatafla 150 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 150 mg
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
quetiapin medical valley forðatafla 50 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 50 mg
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
methotrexate pfizer (methotrexate wyeth) tafla 2,5 mg
pfizer aps - methotrexatum inn - tafla - 2,5 mg
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
quetiapin medical valley forðatafla 200 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 200 mg
Islanda -
Iżlandiż -
LYFJASTOFNUN (Icelandic Medicines Agency)
quetiapin medical valley forðatafla 400 mg
medical valley invest ab - quetiapinum fúmarat - forðatafla - 400 mg
Unjoni Ewropea -
Iżlandiż -
EMA (European Medicines Agency)
zabdeno
janssen-cilag international n.v. - recombinant adenovirus type 26 (ad26) encoding the glycoprotein (gp) of the ebola virus zaire (zebov) mayinga strain - blæðandi hiti, ebóla - bóluefni - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
Unjoni Ewropea -
Iżlandiż -
EMA (European Medicines Agency)
mvabea
janssen-cilag international n.v. - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - blæðandi hiti, ebóla - bóluefni - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.